Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates by Xiaoling Zhou (4644826)

“…The mechanical performance of these materials is strongly governed by the crystalline–amorphous interfaces (CAIs), yet the underlying strengthening and toughening mechanisms remain poorly understood. Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu₅₀Zr₅₀ layers. …”

Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates by Xiaoling Zhou (4644826)

“…The mechanical performance of these materials is strongly governed by the crystalline–amorphous interfaces (CAIs), yet the underlying strengthening and toughening mechanisms remain poorly understood. Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu₅₀Zr₅₀ layers. …”

Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates by Xiaoling Zhou (4644826)

“…The mechanical performance of these materials is strongly governed by the crystalline–amorphous interfaces (CAIs), yet the underlying strengthening and toughening mechanisms remain poorly understood. Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu₅₀Zr₅₀ layers. …”

Layer-Thickness-Dependent Strengthening–Toughening Mechanisms in Crystalline/Amorphous Nanolaminates by Xiaoling Zhou (4644826)

“…The mechanical performance of these materials is strongly governed by the crystalline–amorphous interfaces (CAIs), yet the underlying strengthening and toughening mechanisms remain poorly understood. Here, we employ large-scale molecular dynamics simulations to investigate the compressive deformation of C/A nanopillars composed of alternating equal-thickness crystalline Cu and amorphous Cu₅₀Zr₅₀ layers. …”

S1 File - by Michael Gulledge (20577135)

“…During withdrawal, there was a profound loss (peaking on days 2–3) and gradual return of diurnal structure in sleep, body temperature, and locomotor activity, as well as decreased sleep and wake bout durations dependent on lights on/off. …”

50 ways to trace your veteran: increasing response rates can be cheap and effective by Nicola Townsend Fear (14297773)

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

Decrease in GABA in APP mice. by Ksenia V. Kastanenka (3692380)

of decreased GFR by age and gender. by Hui Song (53547)

Significant decreases in effective connectivity. by Nicola Trotta (424395)

The Reversal Effects of 3-Bromopyruvate on Multidrug Resistance <i>In Vitro</i> and <i>In Vivo</i> Derived from Human Breast MCF-7/ADR Cells by Long Wu (655081)

“…Multidrug resistance reversal by 3-Bromopyruvate occurred through at least three approaches, namely, a decrease in the intracellular level of ATP and HK-II bioactivity, the inhibition of ATPase activity, and the slight decrease in P-glycoprotein expression in MCF-7/ADR cells.…”

No change in muscle size and force, but a decrease in TB mass in 1-mo Lmna^HSA-cko mice. by Lei Xiong (334812)

Luteoloside decreases intracellular ROS. by Shao-hua Fan (527624)

Deformation variation of buried DN50 PE pipeline with different buried depths. by Pengcheng Li (123281)

Leaf chlorophyll <i>a</i>, <i>b</i>, <i>a/b</i>, total chlorophyll, proline and Glycinebetaine (GB) contents of two cultivars of cauliflower (<i>Brassica oleracea</i> L.) plants fo... by Munifa Jabeen (12634746)

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_1_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Data_Sheet_2_Botulinum toxin A decreases neural activity in pain-related brain regions in individuals with chronic ocular pain and photophobia.docx by Nicholas Reyes (16390233)

“…Four to six weeks after BoNT-A injection, unpleasantness scores decreased (48.1 ± 33.6), but the change was not significant. …”

Incidence of Hepatitis C Virus (HCV) in a Multicenter Cohort of HIV-Positive Patients in Spain 2004–2011: Increasing Rates of HCV Diagnosis but Not of HCV Seroconversions by Paz Sobrino-Vegas (680195)

“…<div><p>Objectives</p><p>We aim to describe rates and risk factors of Hepatitis C Virus (HCV) diagnoses, follow-up HCV testing and HCV seroconversion from 2004–2011 in a cohort of HIV-positive persons in Spain.…”